Skip to content

Acupuncture treatment in elderly people with loss of muscle mass: effects on the strenght and inflammatory mediators

Effects of acupuncture on the muscular strength of elderly patients with sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8df2h4
Enrollment
Unknown
Registered
2018-12-27
Start date
2014-06-14
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Group 1 - sample of 11 elderly patients with sarcopenia. Intervention: 24 sessions of systemic acupuncture. Procedures: bioimpedance, dynanometry, Up and Go test and blood sample collection were perfo
Procedure/surgery
H02.004

Sponsors

Universidade Católica de Brasília
Lead Sponsor
Universidade Católica de Brasília
Collaborator

Eligibility

Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: male and female seniors; sedentary; who were not under acunpuncture treatment during the survey period.

Exclusion criteria

Exclusion criteria: Individuals who were afraid of needles; with mobility problems that prevented them to attend the data collection and processing location; who presented difficulties of understanding the treatment and the applied tests

Design outcomes

Primary

MeasureTime frame
Expected outcome: improvement of muscle strength and function after acupuncture intervention. Method used to verify the expected desfection: bioimpedance, dinanometry and test up and go Presentation of the parameters: even if the values ??of the three groups were above the recommended levels, G1 presented the lowest values ??when compared to the other groups, with a significant difference in relation to G2 (p = 0.027) in the Pre and Post 1 moments. However, acupuncture intervention was not able to promote significant changes in body fat levels of G1 (p = 0.358). Values ??of the manual grip strength: G2 had lower values ??than the other groups, with a significant difference at the post-3 moment compared to G3 (p = 0.002). Although there was no statistical difference, G2 and G3 presented manual grip strength, while G1 presented more stable values ??in both limbs. In the evaluation of the functionality, G2 presented a slower TUG test time, but with no statistical significance. This group showed an upward trend in time, whereas G1 and 3 presented similar behavior, with a non-significant reduction of the test time (p = 0.86). From the obtained values ??the delta were calculated, with the pre-moment as covariant and there was no difference.

Secondary

MeasureTime frame
Secondary outcome: Acupuncture in the elderly with sarcopenia may alter the inflammatory markers IL-6, IL-10 and TNF-?. Method used to verify expected outcome: ELISA analysis of inflammatory markers IL-6, IL-10 and TNF-? through blood sample. Presentation of the parameters: Regarding IL-6, all groups presented similar behavior and difference Pos 2 moment in comparison to the pre-moment was annotated (p = 0.05). Even with a slight drop in values, they were still higher than expected (2.08 pg / ml). The values ??of IL-6 and TNF-? generally present direct correlation. In this study there was no relationship between the behavior of IL-6 and TNF-?. The groups showed no difference between them or between the evaluated moments. All groups presented lower than ideal values ??(4.12 pg / ml). IL-10 values ??showed a significant drop in G2 post-3 compared to baseline (p ? 0.001), indicating loss of anti-inflammatory cytokines that confer protection against the oxidative effects of aging. G1 and G3 showed a less significant decrease in IL-10 over the assessed period. All groups completed the study with values ??below the ideal (3.5 pg / ml). From the obtained values, the delta was calculated, with the pre-time as covariant and there was no significant difference.

Countries

Brazil

Contacts

Public ContactGisele Mendes

Universidade Católica de Brasília

gsmendes.fisio@gmail.com+55-061-3448-7116

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 22, 2026